NTLA-2001
Intellia Therapeutics
['crispr']
 crispr technology in vivo trial successfully reduced circulating ttr. game changer #aha22
@YaleCardiology Advanced Imaging fellow. Former @UTSWInternalMed resident.
#Tufts #DoubleJumbo. Tweets are my own.